Azacitidine in Myelodysplastic Syndromes: A Viewpoint by Valeria Santini

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.13, 2005-01, pp. : 1790-1791

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Azacitidine: In Myelodysplastic Syndromes

By Siddiqui M. Asif A. Scott Lesley J.

Drugs, Vol. 65, Iss. 13, 2005-01 ,pp. : 1781-1789

Adis International

Access to resources Recommend Favorite

Azacitidine prolongs survival in myelodysplastic syndromes

Inpharma, Vol. 1, Iss. 1621, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

The role of azacitidine in the treatment of myelodysplastic syndromes

By Abdulhaq Haifaa Rossetti James M

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1967-1975

Informa Healthcare

Access to resources Recommend Favorite

Azacitidine: A Review of its Use in the Management of Myelodysplastic Syndromes/Acute Myeloid Leukaemia

By Keating Gillian M.

Drugs, Vol. 72, Iss. 8, 2012-05 ,pp. : 1111-1136

Adis International

Access to resources Recommend Favorite

Decitabine in Myelodysplastic Syndromes: A Viewpoint by Guillermo Garcia-Manero

By Garcia-Manero Guillermo

Drugs, Vol. 66, Iss. 7, 2006-01 ,pp. : 959-960

Adis International

Access to resources Recommend Favorite